Breakthrough in Pancreatic Cancer Treatment: Understanding the Potential of KRAS G12D Inhibition Pancreatic ductal adenocarcinoma (PDAC) has long remained one of the most challenging diagnoses in oncology. Characterized by aggressive …
Tag: